SMS Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider and approve financial results for the quarter ended 30 September 2026

Date: 28th October, 2026 Corporate Filings Department, Listing Compliance Department, BSE Limited, National Stock Exchange of India Ltd. Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot no. C/1, G Block, Dalal Street, Bandra-Kurla Complex, Bandra (E), Mumbai- 400 001 Mumbai - 400 051. Security Code: 532815 Symbol: SMSPHARMA Dear Sir/Madam, Sub: Intimation of Board Meeting of SMS Pharmaceuticals Limited (“the Company”) to be held on Wednesday, 4th November, 2026. Ref: Regulation 29 of the SEBI (LODR) Regulations, 2015 We would like to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, 4th November, 2026 at the Registered Office of the Company situated at 8th Floor, Trendset Jayabheri Connect, Kondapur, Serilingampally, Ranga Reddy Dist., Hyderabad Telangana - 500084 inter alia to consider and approve the Unaudited (Standalone and Consolidated) Financial Results of the Company for the second quarter and half year ended on 30th September, 2026. In accordance with the Company’s Code of Conduct for Prevention of Insider Trading, pursuant to the amended SEBI (Prohibition of Insider Trading) Regulations, 2015, the Company has already intimated its designated persons including directors regarding the closure of the ‘Trading Window’ for trading in the Company's equity shares from 01st October, 2026, it will remain closed up to 6th November, 2026 (both days inclusive) and shall be re-opened on 7th November, 2026. We request to kindly take note of the same Thanking you Yours faithfully For SMS Pharmaceuticals Limited Thirumalesh Tumma Company Secretary & Compliance Officer